PharmaBoardroom

Juan Sénquiz, President and CEO of JC Automation, weighs in on the capacity of Puerto Rico’s local pharma service industry to grow globally and how…

Leandro Sigman, general manager of Chemo, discusses changes in the Spanish market and the company’s strategy to target international markets.…

José Fernández, president of the Zeltia Group, outlines the company’s strategy for developing oncology drugs through marine-based organisms with…

The history of AmCham Spain dates back to 1917 and has a critical part of developing bilateral relations between Spain and the United States. The…

The past three years have been some of the most eventful in memory for Taiwan‰Ûªs life sciences industry. Buoyed by a successful wave of…

General Manager, Chugai Pharma Taiwan and President of International Research-Based Pharmaceutical Manufacturers’ Association (IRPMA), discusses the…

Vice Chairman of Parexel discusses the benefit of building a company in Taiwan, and the company’s long and short-term goals both domestically and…

An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International…

Prior to joining Kedrion you worked for CSL Behring for a number of years. What opportunities did you see for yourself in moving from there to…

How did you start this journey of founding your company— why medical devices and why Biosensors? I have been in the medical devices industry since…

While, today, you are in charge of voicing the concerns of the innovators in the country, let us first take a step back and see what attracted these…

You took over from your father in 2006. What have been the key milestones & achievements in the company’s development since then and how does…